BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

239 related articles for article (PubMed ID: 36627507)

  • 1. Altered gut microbiota composition in children and their caregivers infected with the SARS-CoV-2 Omicron variant.
    Wang YZ; Zhou JG; Lu YM; Hu H; Xiao FF; Ge T; Wang X; Zheng L; Yu LH; Le J; Yu H; Yu GJ; Xia Q; Zhang T; Zhou WH
    World J Pediatr; 2023 May; 19(5):478-488. PubMed ID: 36627507
    [TBL] [Abstract][Full Text] [Related]  

  • 2. The Relationship Between Pediatric Gut Microbiota and SARS-CoV-2 Infection.
    Romani L; Del Chierico F; Macari G; Pane S; Ristori MV; Guarrasi V; Gardini S; Pascucci GR; Cotugno N; Perno CF; Rossi P; Villani A; Bernardi S; Campana A; Palma P; Putignani L;
    Front Cell Infect Microbiol; 2022; 12():908492. PubMed ID: 35873161
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Intestinal microbiota composition of children with infection with severe acute respiratory syndrome coronavirus 2 (SARS-CoV-2) and multisystem inflammatory syndrome (MIS-C).
    Suskun C; Kilic O; Yilmaz Ciftdogan D; Guven S; Karbuz A; Ozkaya Parlakay A; Kara Y; Kacmaz E; Sahin A; Boga A; Kizmaz Isancli D; Gulhan B; Kanik-Yuksek S; Kiral E; Bozan G; Arslanoglu MO; Kizil MC; Dinleyici M; Us T; Varis A; Kaya M; Vandenplas Y; Dinleyici EC
    Eur J Pediatr; 2022 Aug; 181(8):3175-3191. PubMed ID: 35585256
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Deciphering Gut Microbiota Dysbiosis and Corresponding Genetic and Metabolic Dysregulation in Psoriasis Patients Using Metagenomics Sequencing.
    Xiao S; Zhang G; Jiang C; Liu X; Wang X; Li Y; Cheng M; Lv H; Xian F; Guo X; Tan Y
    Front Cell Infect Microbiol; 2021; 11():605825. PubMed ID: 33869074
    [TBL] [Abstract][Full Text] [Related]  

  • 5. A Pro-Inflammatory Gut Microbiome Characterizes SARS-CoV-2 Infected Patients and a Reduction in the Connectivity of an Anti-Inflammatory Bacterial Network Associates With Severe COVID-19.
    Reinold J; Farahpour F; Fehring C; Dolff S; Konik M; Korth J; van Baal L; Hoffmann D; Buer J; Witzke O; Westendorf AM; Kehrmann J
    Front Cell Infect Microbiol; 2021; 11():747816. PubMed ID: 34869058
    [TBL] [Abstract][Full Text] [Related]  

  • 6. The gut microbiome of COVID-19 recovered patients returns to uninfected status in a minority-dominated United States cohort.
    Newsome RC; Gauthier J; Hernandez MC; Abraham GE; Robinson TO; Williams HB; Sloan M; Owings A; Laird H; Christian T; Pride Y; Wilson KJ; Hasan M; Parker A; Senitko M; Glover SC; Gharaibeh RZ; Jobin C
    Gut Microbes; 2021; 13(1):1-15. PubMed ID: 34100340
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Alterations in Gut Microbiota of Patients With COVID-19 During Time of Hospitalization.
    Zuo T; Zhang F; Lui GCY; Yeoh YK; Li AYL; Zhan H; Wan Y; Chung ACK; Cheung CP; Chen N; Lai CKC; Chen Z; Tso EYK; Fung KSC; Chan V; Ling L; Joynt G; Hui DSC; Chan FKL; Chan PKS; Ng SC
    Gastroenterology; 2020 Sep; 159(3):944-955.e8. PubMed ID: 32442562
    [TBL] [Abstract][Full Text] [Related]  

  • 8. BBIBP-CorV Vaccination against the SARS-CoV-2 Virus Affects the Gut Microbiome.
    Shen Y; Dong Y; Jiao J; Wang P; Chen M; Li J
    Vaccines (Basel); 2023 May; 11(5):. PubMed ID: 37243047
    [TBL] [Abstract][Full Text] [Related]  

  • 9. SARS-CoV-2 infection in nonhuman primates alters the composition and functional activity of the gut microbiota.
    Sokol H; Contreras V; Maisonnasse P; Desmons A; Delache B; Sencio V; Machelart A; Brisebarre A; Humbert L; Deryuter L; Gauliard E; Heumel S; Rainteau D; Dereuddre-Bosquet N; Menu E; Ho Tsong Fang R; Lamaziere A; Brot L; Wahl C; Oeuvray C; Rolhion N; Van Der Werf S; Ferreira S; Le Grand R; Trottein F
    Gut Microbes; 2021; 13(1):1-19. PubMed ID: 33685349
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Exploring gut-lung axis crosstalk in SARS-CoV-2 infection: Insights from a hACE2 mouse model.
    Zhang Y; Ma Y; Sun W; Zhou X; Wang R; Xie P; Dai L; Gao Y; Li J
    J Med Virol; 2024 Jan; 96(1):e29336. PubMed ID: 38193530
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Prolonged Impairment of Short-Chain Fatty Acid and L-Isoleucine Biosynthesis in Gut Microbiome in Patients With COVID-19.
    Zhang F; Wan Y; Zuo T; Yeoh YK; Liu Q; Zhang L; Zhan H; Lu W; Xu W; Lui GCY; Li AYL; Cheung CP; Wong CK; Chan PKS; Chan FKL; Ng SC
    Gastroenterology; 2022 Feb; 162(2):548-561.e4. PubMed ID: 34687739
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Temporal changes in fecal microbiota of patients infected with COVID-19: a longitudinal cohort.
    Galperine T; Choi Y; Pagani JL; Kritikos A; Papadimitriou-Olivgeris M; Méan M; Scherz V; Opota O; Greub G; Guery B; Bertelli C;
    BMC Infect Dis; 2023 Aug; 23(1):537. PubMed ID: 37596518
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Association of gut microbiota with the pathogenesis of SARS-CoV-2 Infection in people living with HIV.
    Ishizaka A; Koga M; Mizutani T; Yamayoshi S; Iwatsuki-Horimoto K; Adachi E; Suzuki Y; Kawaoka Y; Yotsuyanagi H
    BMC Microbiol; 2024 Jan; 24(1):6. PubMed ID: 38172680
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Age-related changes in gut microbiota composition from newborn to centenarian: a cross-sectional study.
    Odamaki T; Kato K; Sugahara H; Hashikura N; Takahashi S; Xiao JZ; Abe F; Osawa R
    BMC Microbiol; 2016 May; 16():90. PubMed ID: 27220822
    [TBL] [Abstract][Full Text] [Related]  

  • 15. The Entero-Mammary Pathway and Perinatal Transmission of Gut Microbiota and SARS-CoV-2.
    Juárez-Castelán CJ; Vélez-Ixta JM; Corona-Cervantes K; Piña-Escobedo A; Cruz-Narváez Y; Hinojosa-Velasco A; Landero-Montes-de-Oca ME; Davila-Gonzalez E; González-Del-Olmo E; Bastida-Gonzalez F; Zárate-Segura PB; García-Mena J
    Int J Mol Sci; 2022 Sep; 23(18):. PubMed ID: 36142219
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Altered gut microbiome associated with metabolic-associated fatty liver disease in Chinese children.
    Ji J; Sun J; Li J; Xie J; Xi B; Zhao M
    Clin Nutr; 2024 Jan; 43(1):187-196. PubMed ID: 38070210
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Gut Microbiota Interplay With COVID-19 Reveals Links to Host Lipid Metabolism Among Middle Eastern Populations.
    Al Bataineh MT; Henschel A; Mousa M; Daou M; Waasia F; Kannout H; Khalili M; Kayasseh MA; Alkhajeh A; Uddin M; Alkaabi N; Tay GK; Feng SF; Yousef AF; Alsafar HS
    Front Microbiol; 2021; 12():761067. PubMed ID: 34803986
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Diagnostic, Prognostic, and Therapeutic Roles of Gut Microbiota in COVID-19: A Comprehensive Systematic Review.
    Farsi Y; Tahvildari A; Arbabi M; Vazife F; Sechi LA; Shahidi Bonjar AH; Jamshidi P; Nasiri MJ; Mirsaeidi M
    Front Cell Infect Microbiol; 2022; 12():804644. PubMed ID: 35310853
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Plasma Microbiome in COVID-19 Subjects: An Indicator of Gut Barrier Defects and Dysbiosis.
    Prasad R; Patton MJ; Floyd JL; Fortmann S; DuPont M; Harbour A; Wright J; Lamendella R; Stevens BR; Oudit GY; Grant MB
    Int J Mol Sci; 2022 Aug; 23(16):. PubMed ID: 36012406
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Dysbiosis of gut microbiota in patients with esophageal cancer.
    Deng Y; Tang D; Hou P; Shen W; Li H; Wang T; Liu R
    Microb Pathog; 2021 Jan; 150():104709. PubMed ID: 33378710
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 12.